Cladribine, Low-Dose Cytarabine (LDAC), and Venetoclax (VEN) in Older/Unfit Acute Myeloid Leukemia (AML) Patients: A Single-Institution Experience

被引：0
|
作者：
Yohannan, Binoy [1 ]
Khan, Hina [1 ]
Cervoni-Curet, Frances [1 ]
Rios, Adan [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
AML; cladribine; low-dose cytarabine; older/unfit AML;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-100
引用
收藏
页码：S267 / S267
页数：1
相关论文
共 50 条
  • [1] Long-Term Follow-Up of a Phase 1/2 Study of Venetoclax (VEN) Plus Low-Dose Cytarabine (LDAC) in Previously Untreated Older Adults with Acute Myeloid Leukemia (AML)
    Wei, Andrew H.
    Strickland, Stephen
    Hou, Jing-Zhou
    Fiedler, Walter
    Lin, Tara L.
    Walter, Roland B.
    Hong, Wan-Jen
    Chyla, Brenda
    Jiang, Qi
    Popovic, Relja
    Hayslip, John
    Roboz, Gail J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S178 - S178
  • [2] Cladribine in the Treatment of Acute Myeloid Leukemia: A Single-Institution Experience
    Martin, Mike G.
    Welch, John S.
    Augustin, Kristan
    Hladnik, Lindsay
    DiPersio, John E.
    Abboud, Camille N.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (04) : 298 - 301
  • [3] Indirect Comparative Effectiveness of Treatments for Older Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (NIC): Combinations Glasdegib plus Low-Dose Cytarabine (GLAS plus LDAC) vs Decitabine or Venetoclax plus LDAC
    Tremblay, G.
    Westley, T.
    Bell, T. J.
    Cappelleri, J. C.
    Chan, G.
    Hearnden, J.
    Forsythe, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 39 - 39
  • [4] Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study
    Ting Zhu
    Li Wang
    Hui Jiang
    Shujuan Huang
    Haitao Xu
    Anyou Wang
    Xin Liu
    Annals of Hematology, 2025, 104 (5) : 2745 - 2753
  • [5] Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia
    Tremblay, Gabriel
    Daniele, Patrick
    Bell, Timothy
    Chan, Geoffrey
    Brown, Andrew
    Cappelleri, Joseph C.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (07) : 603 - 612
  • [6] Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
    Budziszewska, Bozena Katarzyna
    Salomon-Perzynski, Aleksander
    Pruszczyk, Katarzyna
    Barankiewicz, Joanna
    Pluta, Agnieszka
    Helbig, Grzegorz
    Janowska, Anna
    Kuydowicz, Marta
    Bolkun, Lukasz
    Piszcz, Jaroslaw
    Patkowska, Elzbieta
    Watek, Marzena
    Malecki, Piotr
    Kosciolek-Zgodka, Sylwia
    Cichocka, Edyta
    Charlinski, Grzegorz
    Irga-Staniukiewicz, Anna
    Zaucha, Jan Maciej
    Piekarska, Agnieszka
    Gromek, Tomasz
    Hus, Marek
    Wojcik, Karol
    Razny, Malgorzata
    Sedzimirska, Mariola
    Pula, Bartosz
    Giebel, Sebastian
    Grosicki, Sebastian
    Wierzbowska, Agnieszka
    Lech-Maranda, Ewa
    CANCERS, 2021, 13 (16)
  • [7] Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
    Andrius Zucenka
    Kazimieras Maneikis
    Birute Pugaciute
    Ugne Ringeleviciute
    Austeja Dapkeviciute
    Linas Davainis
    Guoda Daukelaite
    Paulina Burzdikaite
    Vytautas Staras
    Laimonas Griskevicius
    Annals of Hematology, 2021, 100 : 1195 - 1202
  • [8] Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
    Zucenka, Andrius
    Maneikis, Kazimieras
    Pugaciute, Birute
    Ringeleviciute, Ugne
    Dapkeviciute, Austeja
    Davainis, Linas
    Daukelaite, Guoda
    Burzdikaite, Paulina
    Staras, Vytautas
    Griskevicius, Laimonas
    ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1195 - 1202
  • [9] An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia
    Othman, Tamer A.
    Tenold, Matthew E.
    Moskoff, Benjamin N.
    Azenkot, Tali
    Jonas, Brian A.
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (05) : 407 - 417
  • [10] Fix low dose venetoclax-azacitidine treatment of unfit acute myeloid leukemia patients
    Miklos, Egyed
    Oliver, Toth Peter
    Adam, Kellner
    Eva, Karadi
    Balazs, Kollar
    Eszter, Kovacs
    Anett, Pavlovics
    Viktoria, Gyori-Korom
    Jozsef, Herczeg
    Peter, Rajnics
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (02) : 183 - 189
12345